Vpriv

Active Ingredient(s): Velaglucerase Alfa
FDA Approved: * February 26, 2010
Pharm Company: * SHIRE
Category: Enzymes

Velaglucerase alfa, sold under the brand name Vpriv and manufactured by Shire plc, is a hydrolytic lysosomal glucocerebroside-specific enzyme, which is a recombinant form of glucocerebrosidase indicated as a long-term enzyme replacement therapy for those suffering of Gaucher disease Type 1. It has an identical amino acid sequence to the naturally occurring enzyme.[1] It was approved for use by the U.S. Food and Drug Administration (FDA) on February 26, 2010.[2]... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Vpriv 2.5 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 54092-701
Labeler:
Shire Us Manufacturing Inc.